Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DMB-3115 vs Stelara in Moderate to Severe Chronic Plaque Psoriasis
NCT04785326Phase 3Completed
- Sponsor
- Dong-A ST
- Start
- Apr 2021
- Primary completion
- Feb 2022
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of dmb-3115 in plaque psoriasis, sponsored by Dong-A ST. Started Apr 2021; status: completed.
02
Drugs
dmb-3115
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT04785326.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04785326.